Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / MED BREAKTHGH
-
Total 13F shares
-
1,459,524
-
Share change
-
+488,171
-
Total reported value
-
$44,254,889
-
Put/Call ratio
-
28%
-
Price per share
-
$30.38
-
Number of holders
-
45
-
Value change
-
+$14,757,407
-
Number of buys
-
10
-
Number of sells
-
22
Institutional Holders of ALPS ETF TR - MED BREAKTHGH (SBIO) as of Q4 2022
As of 31 Dec 2022,
ALPS ETF TR - MED BREAKTHGH (SBIO) was held by
45 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,459,524 shares.
The largest 10 holders included
DAVENPORT & Co LLC, MORGAN STANLEY, BANK OF AMERICA CORP /DE/, UBS Group AG, Raymond James Financial Services Advisors, Inc., Royal Bank of Canada, NTV Asset Management LLC, Beacon Pointe Advisors, LLC, Strategic Financial Services, Inc,, and CITADEL ADVISORS LLC.
This page lists
45
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.